This company is not actively trading or the ticker does belong to another company in our database now. The symbol (NONE`) is currently associated with the following stock:
Canistel Acquisition Corp (NONE`)
Insider Roster Marek Honczarenko, Evp & Chief Scientific Officer, 2025-10-01 Christiana Stamoulis, President and Cfo, 2025-09-25 B. Frank Raciti, Controller & Cao, 2025-08-28 Jon Zinman, Director, 2025-08-19 J Marc Yoskowitz, Director, 2025-08-19 O Sigurdur Olafsson, President and Ceo, 2025-08-19 D. Sophia Langlois, Director, 2025-08-19 Scott Hirsch, Director, 2025-08-19 Paul Efron, Director, 2025-08-19 Katina Dorton, Director, 2025-08-19 E Leslie Donato, Director, 2025-08-19 Paul Bisaro, Director, 2025-08-19 Goldentree Asset Management Llc, Large Shareholder, 2025-08-06 A. Steven Tananbaum, Large Shareholder, 2025-08-06 Goldentree Asset Management Lp, Large Shareholder, 2025-08-06 Paul Hugh Oneill, Evp, Qual & Ops, Spec Brands, 2025-08-05 Henriette Nielsen, Evp & Chief Transformation Ofc, 2025-08-05 Abbas Hussain, Director, 2025-08-05 Ann Susan Williamson, Evp & Chief Compliance Officer, 2025-08-05 Lisa French, Evp & Chief Commercial Officer, 2025-08-05 Wesley Wheeler, Director, 2025-08-05 Andrew Stephen Welch, Evp & Head Of Spec Generics, 2025-08-05 Anthony Mark Tyndall, Evp & Clo and Corp Sec, 2025-08-05 Ann Cheryl Stouch, Evp & Chief Info Officer, 2025-08-05 J. David Stetson, Director, 2025-08-05 T. Mark Bradley, Evp, Chief Integration Officer, 2025-08-05 C Peter Richardson, Evp & Chief Scientific Officer, 2025-08-05 M. Bryan Reasons, Evp & Cfo, 2025-08-05 Tracy Basso, Evp & Chro, 2025-08-05 Kassie Harrold, Evp & Chief Compliance Officer, 2025-01-02 Daniel Jason Goodson, Evp & Chief Strategy Officer, 2025-01-02 R.l. S.a Iii Ffi, Large Shareholder, 2023-11-17 Bracebridge Capital, Llc, Large Shareholder, 2023-11-17 R.l. S.a Luxco Olifant, Large Shareholder, 2023-11-17 R.l. S.a Fyi, Large Shareholder, 2023-11-17 P Neal Goldman, Director, 2023-11-16 Jr A Woodrow Myers, Director, 2023-11-16 Michele Susan Silbermann, Director, 2023-11-16 Hussein Riad El-Dada, Director, 2023-11-16 Karen Ling, Director, 2023-11-16 Arthur Daniel Celentano, Director, 2023-11-16 R James Sulat, Director, 2023-11-16 Alta Fundamental Advisers Llc, Large Shareholder, 2023-06-23 Clem Anne Whitaker, Director, 2022-06-21 Y David Norton, Director, 2022-06-21 V Carlos Paya, Director, 2022-06-21 Martin J Carroll, Director, 2022-06-21 A Joann Reed, Director, 2022-06-21 Kneeland Dr Youngblood, Director, 2022-06-21 Mark Trudeau, President and Ceo, 2022-06-21 R David Carlucci, Director, 2022-06-21 M. Hugh O'neill, See Remarks, 2022-06-21 Rutherford Paul Carter, Director, 2022-06-21 J Mark Casey, Evp & Chief Legal Officer, 2022-06-21 C. Angus Russell, Director, 2022-06-21 J. Steven Romano, Evp & Chief Sci. Ofcr, 2022-06-21 J Ian Watkins, See Remarks, 2022-06-21 A Kathy Schaefer, Sr. Vp Fin & Corp. Controller, 2021-04-05 Dagmar Rosa-Bjorkeson, Chief Strat & Corp Dev Officer, 2019-06-04 A Joseph Zaccagnino, Director, 2019-05-17 Patruno Karen Sheehy, Chief Compliance Officer, 2019-04-03 Frank Scholz, Evp & Chf Ops & Dig Innov Off, 2019-04-03 K Matthew Harbaugh, Evp & President, Spec Gen, 2019-04-03 A. George Kegler, Evp & Cfo, Interim, 2019-01-11 L.p. Mgmt Deerfield, Large Shareholder, Other, 2018-05-10 Deerfield Management Company, L.p. (Series C), Large Shareholder, Other, 2018-05-10 Deerfield Partners, L.p., Large Shareholder, Other, 2018-05-10 E James Flynn, Large Shareholder, Other, 2018-05-10 K. Ronald Lloyd, Exec. Vp & Pres, Hospital, 2018-04-04 H. Diane Gulyas, Director, 2018-03-05 D Melvin Booth, Director, 2018-03-05 Michael-Bryant Hicks, General Counsel, 2018-01-06 Iii N Coleman Lannum, Sr. Vp Investor Strategy & Iro, 2018-01-06 M. Gary Phillips, Exec. Vp & Chief Strategy Ofcr, 2018-01-06 B Meredith Fischer, Chief Public Affairs Officer, 2018-01-06 D Virgil Thompson, Director, 2017-03-03 J. Raymond Furey, Chief Compliance Officer, 2017-01-06 Nancy Lurker, Director, 2016-03-18 M Don Bailey, Director, 2016-03-18 L Terrance Carlson, Interim General Counsel, 2015-12-15 G Peter Edwards, Sr. Vp & General Counsel, 2015-05-29 D. Mario Saltarelli, Sr. Vp & Chief Science Ofcr., 2015-05-19 L Sandra Hatten, Sr. Vp, Quality, 2015-05-12 Daniel Tasse, Interim Pres-Hospital Business, 2015-05-04 Paulson & Co Inc, Large Shareholder, 2014-08-15 Stephen Merrick, Sr. Vp & Pres. Commercial Intl, 2014-03-03 Ltd Holding Enceladus, Other, 2013-07-03 R Stefano Carchedi, See Remarks, 2013-07-03 E Thomas Berry, See Remarks, 2013-07-03 David Keenan, Director, 2013-06-13 Show All Insiders (90) Filing Period: 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31
Last updated on February 14, 2022, 2:32pm based on SEC 13F filings Last update: February 14, 2022, 2:32pm
No. Hedge Fund Shares Value Activity % Port 1. 0 $0 0% 2. 0 $0 0% 3. 0 $0 0% 4. 0 $0 0% 5. 0 $0 0%
Insider Price Amount Total Value Remaining Holdings Date Form 4 Large Shareholder
$92.50 6,700 $619,750.00 7,946,176 2025-08-06 Filing Large Shareholder
$87.25 30,000 $2,617,500.00 7,939,476 2025-08-04 Filing Large Shareholder
$86.50 50,000 $4,325,000.00 7,909,476 2025-08-01 Filing Large Shareholder
$54.50 13,300 $724,850.00 3,327,335 2024-07-08 Filing Large Shareholder
$52.75 275,000 $14,506,250.00 3,314,035 2024-06-14 Filing
Insider Price Amount Total Value Remaining Holdings Date Form 4 Director
$0.12 22,087 $2,575.34 0 2022-03-17 Filing Director
$0.12 11,978 $1,401.43 22,087 2022-03-17 Filing Officer
$0.26 2,100 $537.18 76,856 2021-08-05 Filing Director
$0.26 5,080 $1,334.01 0 2021-08-05 Filing Director
$0.40 16,614 $6,715.38 0 2021-03-12 Filing
Filing Period: 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 1987-03-31 0000-00-00
No. Name Shares Value % Port 1. 1 $0 0%